20-F XBRL

FORM 20-F

Company: NYMOX PHARMACEUTICAL CORP
Filed: March 29, 2019
Period of Report: December 31, 2018
Accession Number: 0001640334-19-000464

View Document ↗ View on SEC.gov ↗